We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Editorial: Intravenous Iron for the Treatment of Iron Deficiency in IBD: the Pendulum Is Swinging.
- Authors
Van Assche, Gert
- Abstract
Abstract: Intravenous (IV) iron therapy has been a major asset in the management of refractory iron-deficiency anemia in inflammatory bowel disease (IBD) and other diseases. However, the cost-effectiveness of parenteral substitution as the first-line treatment of this condition in IBD has been questioned. A study published by Reinisch et al. in this issue of the journal fails to show non-inferiority of iron isomaltose 1,000, a novel high-dose IV preparation, compared to oral iron sulfate.
- Subjects
INTRAVENOUS therapy; THERAPEUTIC use of iron; IRON deficiency anemia treatment; INFLAMMATORY bowel diseases; DOSAGE forms of drugs; COST effectiveness
- Publication
American Journal of Gastroenterology (Springer Nature), 2013, Vol 108, Issue 12, p1889
- ISSN
0002-9270
- Publication type
Article
- DOI
10.1038/ajg.2013.400